Suppr超能文献

伯氏疏螺旋体的体外和体内药敏性

In vitro and in vivo susceptibility of Borrelia burgdorferi.

作者信息

Mursic V P, Wilske B, Schierz G, Holmburger M, Süss E

机构信息

Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of Munich, FRG.

出版信息

Eur J Clin Microbiol. 1987 Aug;6(4):424-6. doi: 10.1007/BF02013102.

Abstract

The antispirochetal activity in vitro and in vivo of several antibiotics against ten isolates of Borrelia burgdorferi from human spinal fluids and skin biopsies was determined. Borrelia burgdorferi was most susceptible in vitro to erythromycin, ceftriaxone and cefotaxime (MIC90: 0.06, 0.06, 0.12 mcg/ml respectively). Less activity was observed with tetracycline, amoxycillin and lincomycin (MIC90: 0.50 mcg/ml), imipenem and augmentin (MIC90: 0.25 mcg/ml), oxacillin (MIC90: 1 mcg/ml), ciprofloxacin (MIC90: 2 mcg/ml) and ofloxacin (MIC90: 4 mcg/ml). Penicillin G, normally regarded as appropriate treatment for Lyme disease, had an MIC90 of only 4 mcg/ml. With the exception of erythromycin, activity in vitro corresponded to the activity in vivo. Erythromycin, however, was less active in vivo, and penicillin G showed poor activity both in vitro and in vivo.

摘要

测定了几种抗生素对从人体脑脊液和皮肤活检组织中分离出的10株伯氏疏螺旋体的体外和体内抗螺旋体活性。伯氏疏螺旋体在体外对红霉素、头孢曲松和头孢噻肟最为敏感(MIC90分别为:0.06、0.06、0.12微克/毫升)。四环素、阿莫西林和林可霉素(MIC90:0.50微克/毫升)、亚胺培南和奥格门汀(MIC90:0.25微克/毫升)、苯唑西林(MIC90:1微克/毫升)、环丙沙星(MIC90:2微克/毫升)和氧氟沙星(MIC90:4微克/毫升)的活性较低。通常被认为是莱姆病合适治疗药物的青霉素G,其MIC90仅为4微克/毫升。除红霉素外,体外活性与体内活性相符。然而,红霉素在体内活性较低,青霉素G在体外和体内均表现出较差的活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验